I can't help but think, based on a previous webinar where BOT brought in the head honcho of the IHS, who said that they would be emailing out to their 50k strong email database about Sofdra, that the IHS is coordinating with BOT to share more info on Sofdra most likely pending the Patient Experience launch. I notice they haven't updated their website yet to include Sofdra as one of the available treatments (let alone the best available treatment), so it does make me think there is a more coordinated approach here pending.
I can't help but think, based on a previous webinar where BOT...
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $581.5M | |||
| Open | High | Low | Value | Volume |
| 32.5¢ | 32.5¢ | 31.5¢ | $1.940M | 6.061M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 17 | 470483 | 31.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.0¢ | 33000 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| BOT (ASX) Chart |